Incretin-based therapies

Incretin-based therapies have established a foothold in the diabetes armamentarium through the introduction of oral dipeptidyl peptidase-4 inhibitors and the injectable class, the glucagon-like peptide-1 receptor agonists. In 2009, the American Diabetes Association and European Association for the S...

Descripción completa

Detalles Bibliográficos
Autores principales: Stonehouse, Anthony H, Darsow, Tamara, Maggs, David G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380568/
https://www.ncbi.nlm.nih.gov/pubmed/21707956
http://dx.doi.org/10.1111/j.1753-0407.2011.00143.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380568/
https://www.ncbi.nlm.nih.gov/pubmed/21707956
http://dx.doi.org/10.1111/j.1753-0407.2011.00143.x

Ejemplares similares